Similar articles

• Mixture classification model based on clinical markers for breast cancer prognosis.

  Zeng T, Liu J. Zeng T, et al. Artif Intell Med. 2010 Feb-Mar;48(2-3):129-37. doi: 10.1016/j.artmed.2009.07.008. Epub 2009 Dec 14. Artif Intell Med. 2010. PMID: 20005686
• Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients.

  Retsky M, Bonadonna G, Demicheli R, Folkman J, Hrushesky W, Valagussa P. Retsky M, et al. Breast Cancer Res. 2004;6(4):R372-4. doi: 10.1186/bcr804. Epub 2004 May 14. Breast Cancer Res. 2004. PMID: 15217504 Free PMC article.
• Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients.

  Cheng SH, Horng CF, Clarke JL, Tsou MH, Tsai SY, Chen CM, Jian JJ, Liu MC, West M, Huang AT, Prosnitz LR. Cheng SH, et al. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1401-9. doi: 10.1016/j.ijrobp.2005.11.015. Epub 2006 Feb 10. Int J Radiat Oncol Biol Phys. 2006. PMID: 16472935 Clinical Trial.
• Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.

  Albain KS, Paik S, van't Veer L. Albain KS, et al. Breast. 2009 Oct;18 Suppl 3:S141-5. doi: 10.1016/S0960-9776(09)70290-5. Breast. 2009. PMID: 19914534 Review.
• Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer.

  Fleshner N, Keane TE, Lawton CA, Mulders PF, Payne H, Taneja SS, Morris T. Fleshner N, et al. Prostate Cancer Prostatic Dis. 2008;11(1):46-52. doi: 10.1038/sj.pcan.4500982. Epub 2007 Jul 3. Prostate Cancer Prostatic Dis. 2008. PMID: 17607304 Review.